Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
03/1998
03/17/1998US5728815 Bone and prostate-derived protein factors affecting prostate cancer growth, differentiation, and metastasis
03/17/1998US5728814 Monoclonal antibodies, hybridoma cell line
03/17/1998US5728813 Antibodies directed against elk ligand
03/17/1998US5728812 Anti-idiotypic antibody composition for inhibiting acute complement-mediated cytotoxicity
03/17/1998US5728806 TIH1, protein that interacts with casein kinase I
03/17/1998US5728679 BMP-15 compositions
03/17/1998US5728677 Administering a specified polypeptide to a mammal
03/17/1998US5728552 DNA encoding a fusion protein comprising a viral antigen and lymphokine
03/17/1998US5728549 Gene expression vectors with controlling sequences of dna
03/17/1998US5728537 Antigen immunogens for cancer detection in epithelial fluids
03/17/1998US5728536 Jak kinases and regulation of Cytokine signal transduction
03/17/1998US5728533 Human β2 integrin αsubunit
03/17/1998US5728520 Immunoreactive polypeptide compositions
03/17/1998US5728369 Radioactive phosphorus labeling of proteins for targeted radiotherapy
03/17/1998CA1339737C Fibrin-specific and fibrinogen-specific monoclonal antibodies and their derivation from immunized germ free mice
03/17/1998CA1339734C Bacillus thuringiensis transformation
03/17/1998CA1339730C Monoclonal antibiodies and methods for fungal pathogen detection
03/12/1998WO1998010292A1 Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen
03/12/1998WO1998010287A1 A screening assay for thrombin receptor antagonists
03/12/1998WO1998010284A1 Purification of antigen-specific t cells
03/12/1998WO1998010100A1 Method and kit for the diagnosis of blackcurrant reversion disease
03/12/1998WO1998010070A1 HUMANIZED IMMUNOGLOBULIN REACTING SPECIFICALLY WITH Fas LIGAND OR ACTIVE FRAGMENTS THEREOF AND REGION INDUCING APOPTOSIS ORIGINATING IN Fas LIGAND
03/12/1998WO1998010066A1 Modulators of brca1 activity
03/12/1998WO1998010065A1 Breast carcinoma-associated gene
03/12/1998WO1998010056A1 Treatment of antigen presenting cells to modulate antigen presenting cell function
03/12/1998WO1998009992A2 HTm4, METHODS OF TREATMENT AND ASSAYS, AGONISTS AND ANTAGONISTS
03/12/1998WO1998009980A1 Bh3 interacting domain death agonist
03/12/1998WO1998009651A1 ANTI-INTEGRIN α3 ANTIBODY COMPLEXES
03/12/1998WO1998009643A1 Modulation of apoptosis by serine phosphorylation of blc-xl/blc-2 associated cell death regulator
03/12/1998WO1998009639A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998WO1998009638A1 INHIBITION OF MAST CELL ACTIVATION BY gp49-BASED MECHANISMS AND REAGENTS
03/12/1998WO1998009505A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998WO1998004585A3 Novel human macrophage antigen
03/12/1998WO1997046259A3 Chimeric toxin for targeted therapy
03/12/1998DE19638745A1 Monoklonale Antikörper gegen die extrazelluläre Domäne des menschlichen VEGF - Rezeptorproteins (KDR) Monoclonal antibodies against the extracellular domain of the human VEGF - receptor protein (KDR)
03/12/1998CA2264968A1 Humanized immunoglobulin reacting specifically with fas ligand or active fragments thereof and region inducing apoptosis originating in fas ligand
03/12/1998CA2264845A1 Novel bacteriocins, transport and vector system and method of use thereof
03/12/1998CA2264578A1 Bh3 interacting domain death agonist
03/12/1998CA2264490A1 Htm4, methods of treatment and assays, agonists and antagonists
03/12/1998CA2264489A1 Plant retroviral polynucleotides and methods for use thereof
03/12/1998CA2259959A1 Modulators of brca1 activity
03/11/1998EP0827963A2 Synthesis of galactosylhydroxylysine, antibodies to galactosylhydroxylysine, and method of assaying for galactosylhydroxylysine
03/11/1998EP0827591A1 Method for diagnosing a patient for chlamydia
03/11/1998EP0827544A2 Multimeric proteins
03/11/1998EP0827541A1 A method and nucleotide sequence for transforming microorganisms
03/11/1998EP0827537A2 Chromatin-regulator genes
03/11/1998EP0827513A1 Methods of treatment and diagnostic visualisation, particularly in cancer
03/11/1998EP0827512A1 ANTIBODY SPECIFIC FOR $i(STAPHYLOCOCCUS AUREUS), AND USE THEREOF
03/11/1998EP0827509A1 Modulation of cholesteryl ester transfer protein (cetp) activity
03/11/1998EP0827409A1 Compositions and methods for inhibiting xenograft rejection
03/11/1998CN1175958A Monoclonal antiidiotypic antibodies (AB2) and uses thereof
03/11/1998CN1175957A Monoclonal antibodies anti-CD6 and their uses
03/11/1998CN1175956A Novel protein and method for production of same
03/11/1998CN1175954A Isolated nonapeptides presented by HLA molecules, and uses thereof
03/10/1998US5726304 Porphocyanine and CNC-expanded porphyrins
03/10/1998US5726298 Epimorphin and its encoding nucleic acids
03/10/1998US5726293 Affinity purification methods involving imidazole elution
03/10/1998US5726290 Soluble analogues of integrins
03/10/1998US5726288 Dna with nucleic acid sequence
03/10/1998US5726286 Isolated epstein-barr virus BZLF2 proteins that bind MHC class II beta chains
03/10/1998US5726169 Chlorophyll and bacteriochlorophyll derivatives, their preparation and pharmaceutical compositions comprising them
03/10/1998US5726044 Expression and export technology of proteins as immunofusins
03/10/1998US5726037 Host cells and method of producing soluble analogues of integrins
03/10/1998US5726036 Granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof
03/10/1998US5726027 Method for treatment of insulin resistance
03/10/1998US5726024 p53as protein and antibody therefor
03/10/1998US5726023 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the HER-2/neu oncogene is associated
03/10/1998US5726018 Nucleic acid based assays to detect a novel mammalian protein associated with uncontrolled cell division
03/10/1998US5725873 Method of improving the growth or the efficiency of feed conversion of an animal and compositions for use therein
03/10/1998US5725856 Anticarcinogenic agents and antitumor agents
03/10/1998US5725855 Method of treating tumors with CD8+ -depleted or CD4+ T cell subpopulations
03/10/1998US5725839 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
03/10/1998CA1339709C Monoclonal antibodies to human pancreatic cancer
03/05/1998WO1998009170A2 Methods and compositions for the detection of cervical cancer
03/05/1998WO1998009169A1 Method for detecting kinase activity
03/05/1998WO1998008957A1 Compositions and methods for specifically targeting tumors
03/05/1998WO1998008955A1 Stimulus-inducible i (kappa)b kinase [ikk] signalsome
03/05/1998WO1998008953A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998WO1998008951A1 New brucella antigens, recombinant polypeptides, nucleic acids coding for the same and use thereof in diagnostic and prophylactic methods and kits
03/05/1998WO1998008949A1 P-selectin ligand proteins
03/05/1998WO1998008945A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998WO1998008933A1 Kuz, a novel family of metalloproteases
03/05/1998WO1998008875A1 Novel combination preparations and their use in immunodiagnosis and immunotherapy
03/05/1998WO1998008874A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions
03/05/1998WO1998008870A1 Interleukin-19
03/05/1998WO1998008864A1 FIBROBLAST GROWTH FACTOR HOMOLOGOUS FACTORS (FHFs) AND METHODS OF USE
03/05/1998WO1998008603A1 Isolation of immunoglobulins
03/05/1998WO1998008542A2 Compounds and methods for treatment and diagnosis of mycobacterial infections
03/05/1998WO1998008541A1 Inhibition of primary and/or secondary immune response to repeat adenoviral vector administration using cd40l specific antibodies
03/05/1998WO1998008540A1 Multivalent vaccine for clostridium botulinum neurotoxin
03/05/1998WO1998008381A1 Therapeutic and diagnostic applications of perlecan domain i splice variants
03/05/1998WO1998008371A1 Monoclonal antibodies specific to cooked meats
03/05/1998WO1998002548A3 Infectious papillomavirus pseudoviral particles
03/05/1998WO1997033615A3 Caprine arthritis-encephalitis virus provides immunoprotection against hiv-1 infection
03/05/1998DE19634730A1 Bispecific antibodies, useful for imaging, diagnosis and treatment
03/05/1998CA2296765A1 Soluble recombinant botulinum toxin proteins
03/05/1998CA2265088A1 Use of herpes simplex virus orf p protein in repression of viral protein synthesis and related methods
03/05/1998CA2264576A1 Protein inhibitor of neuronal nitric oxide synthase
03/05/1998CA2264548A1 Interleukin-19
03/05/1998CA2264177A1 Isolation of immunoglobulins
1 ... 1282 1283 1284 1285 1286 1287 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 ... 1494